These conversations dig into the multi-faceted questions that keep ophthalmology executives awake at night. Host Kristine Morrill examines business innovations and ideas in ophthalmology field in Europe, supported by industry experts.
With over 30 years experience in healthcare, Kris contributes a robust knowledge
that frames dynamic conversations you won’t want to miss.
The Business of Eye Innovation Podcast
The IOL: Celebrating 75 Years
On this episode, we reflect on the significance of the IOL in modern eye care and the impact created by it’s invention 75 years ago. Together with Tim Clover (CEO of Rayner), David Lockington (president-elect UKISCRS), and Paul Ursell (incumbent president UKISCRS), we discuss what the IOL has meant for the evolution of eye care, and how our field is celebrating this important innovation.
An Interview with Dr. Filomena Ribeiro: 2024 is the Year of Diversity for ESCRS
Dr. Filomena Ribeiro talks with us about the ESCRS Year of Diversity initiative for 2024 as well as the upcoming Winter Meeting 2024 in Frankfurt.
Don’t have time to listen right now? Read the key takeaways here.
American Companies Doing Business in France
On this episode of the BOEI Podcast, we’re talking about the cultural, logistic, and talent aspects of doing business in France, from the perspective of Americans and American businesses. Specifically, what American medtech and healthcare businesses should consider when weighing a location in the region of Alsace. We are joined by three American professionals who each have deep experience working and growing businesses in France.
Don’t have time to listen right now? Read the key takeaways here.
Having a firm grasp in basic statistics is beneficial and often critical to preparing an article for peer review. While clinical researchers often work with a statistician for data analysis, it is helpful for clinicians to understand the basic statistical principles to provide more valuable insight. Dr. Angeli Yu leads this discussion of statistics for peer-reviewed manuscripts.
Don’t have time to listen right now? Read the key takeaways here.
Transforming Clinical Data
into a Peer-Reviewed Article (Part 2)
Transforming Clinical Data
into a Peer-Reviewed Article (Part 1)
Writing a successful clinical manuscript for peer review can be challenging. In this episode, Prof. Dr. Stephanie Joachim, Head of Experimental Eye Research at Ruhr University in Buchum, provides expert step-by-step guidance on developing a strong manuscript for peer review and publication. Dr. Joachim is highly published and serves as an editorial board member on several scientific journals. Also joining is Clotilde Jumelle, Regulatory Project Manager and part of the Medevise Clinical Writing Team.
Don’t have time to listen right now? Read the key takeaways here.
Two Years of Medevise
Medevise was founded two years ago, so we took this opportunity to chat with our board of directors about the company’s mission, the market need that Medevise fills, its rapid growth, and the vision for what’s next.
Don’t have time to listen right now? Read the key takeaways here.
Europe’s First MedTech Innovation Campus: Nextmed
The NextMed campus in Strasbourg is a center for medtech start-ups, entrepreneurs, surgeons, researchers, and students to develop cutting edge technologies and innovations. On this episode of the BOEI Podcast, Kris Morrill talks with NextMed Director Nicolas Pellerin about the significance of the NextMed campus, how it came to be, the critical role it plays in fueling innovation, and his vision for future expansion.
Don’t have time to listen right now? Read the key takeaways here.
Managing Successful Clinical Studies
If you’ve wondered how Medevise takes a medical device through the MDR to a CE mark, listen in as Claire, Xavier, and Anne-Sophie take listeners though our clinical team’s process and secrets to achieving faster approvals from ethics committees and competent authorities.
Don’t have time to listen right now? Read the key takeaways here.
New Ophthalmic Developments from Europe
Dr. Arthur Cummings recently polled several of his European ophthalmology colleagues about their favorite cutting-edge technologies and tools, which he shared at the AECOS 2023 winter conference in Aspen, Colorado. Now, he’s sharing these exciting insights with us on this episode of the Business of Eye Innovation podcast.
Don’t have time to listen right now? Read the key takeaways here.
Facing Europe’s MDR Head-On
We’re talking all about the MDR with legal expert Erik Vollebregt, including the impact on manufacturers from the most recent vote by the European Parliament to extend the MDR transition periods. The MDR is not on hold, and it isn’t the extension that some manufacturers think.
Listen in to learn what’s really going on with the MDR. Don’t have time to listen right now? Read the key takeaways here.
Diversity & Inclusion in Ophthalmology from a US & EU Perspective
On this episode of the BOEI Podcast, Founder and President of Medevise Consulting, Kristine Morrill, sits down with Professor Eve J. Higginbotham and Dr. Mor M. Dickman to discuss the current state of affairs in diversity & inclusion in ophthalmology, as well as how aspiring ophthalmologists can build the career they want.
Don’t have time to listen right now? Read the key takeaways here.
ESCRS Practice Management Preview
Episode 8 of the Business of Eye Innovation Podcast brings together ESCRS Practice Management & Development Program creators: Mr. Paul Rosen and Colin Kerr with their collaborator, our own President & Founder, Kristine Morrill.
Don’t have time to listen right now? Read the key takeaways here.
DOC Congress Preview: LumiThera Showcasing Valeda Light Delivery System and Latest LIGHTSITE III Data
Medevise Director of Medical Communications and Marketing, Rebecca Rose, talks with LumiThera Co-Founder, President, and CEO Dr. Clark Tedford about the company’s plans for the upcoming DOC congress, their Valeda Light Delivery System, and the LIGHTSITE III study.
Don’t have time to listen right now? Read the key takeaways here.
Investment in the Medical Technology Field, with Post-COVID Considerations
Kris Morrill speaks to Joe Mandato, a partner at DeNovo Ventures and a recognized leader in the field of life sciences. Joe is active on several boards in the healthcare industry and serves as a lecturer at Stanford University, where he teaches an undergraduate course on Medical Device Innovation at the Byers Center for Biodesign. He lives in Palo Alto, California.
Don’t have time to listen right now? Read the key takeaways here.
Understanding the MDR and Its Complexities
Erik Vollebregt is a Partner at Axon Lawyers who specializes in EU and national legal and regulatory issues relating to medical devices, including eHealth, mHealth, software and protection of personal data. He is an expert in life sciences regulation at EU and Dutch level, with a focus on contracts, regulatory litigation against competent authorities and M&A.
Don’t have time to listen just now? Read more here.
Dancing to the Tune of High Performance
The Business of Eye Innovation podcast speaks to Bernie Haffey, physics teacher and sports coach turned ophthalmology entrepreneur, management consultant and author about his new book, career highlights, what it takes to create a High Performance Management System.
Don’t have time to listen right now? Read the key takeaways here.
From Clinical Practice to Clinical Study Site
The Business of Eye Innovation podcast takes an in-depth look at clinical trials – looking at the need for them as well as what it takes to be a leading site for these involved studies. Host Victor Benedetti talks with Dr. Vance Thompson, a leading ophthalmologist specializing in cataract surgery and Keeley Puls-Boever who oversees clinical trials at Vance Thompson Vision.
Don’t have time to listen right now? Read the key takeaways here.
Rayner Re-imagined
In our second episode of The Business of Eye Innovation, we lift the lid on the re-imagination of British ophthalmology stalwart, Rayner Intraocular Lenses, as Medevise Founder, Kristine Morrill, speaks to the inspiring duo of CEO, Tim Clover and VP of Marketing, Chris Willis.
Don’t have time to listen right now? Read the key takeaways here.